Skip to content
Screener

Cytek Biosciences, Inc. CTKB Product — Total cost of sales

Other product segments

Service
$6.92M+1.5%

Similar metrics at other companies

Everspin Technologies logo
MRAMProduct sales — Total cost of sales
$8.3M+34.5%
Cisco Systems, Inc. logo
CSCOProduct — Total cost of sales
$4.61B+25.1%
NGL Energy Partners logo
NGLProduct — Total cost of sales
$726.83M+4.6%
Penguin Solutions logo
PENGProduct — Total cost of sales
$313.04M+56.5%
3D Systems logo
DDDProducts — Total cost of sales
$36.09M-3.4%
Quad Graphics logo
QUADProducts — Total cost of sales
$375.8M+2.0%

Other financials

Income statement

See full
Revenue$48.1M+5.6%
Gross profit$28.3M+18.7%
Operating income-$11.4M-7.3%
Net income-$12.2M-118%
EPS (diluted)-$0.09-125%

Balance sheet

See full
Cash & equivalents$73.8M-2.2%
Total debt$17.0M-6.6%
Total equity$322.0M-14.7%
Total assets$446.9M-9.4%

Cash flow

See full
Operating cash flow-$2.7M-2,089%
CapEx$2.2M+40.5%
Free cash flow-$849.0K+42.2%

Valuation

See full
Market cap$545.93M+25.6%
Enterprise value$489.11M+29.2%
P/S2.6×+0.4×

Profitability

See full
Gross margin53.2%-1.2pp
Operating margin-21.6%
Net margin-39%
FCF margin-5.8%-11.4pp

Returns & leverage

See full
Return on equity-23%
Debt / equity0.1×0.0×
Current ratio4.5×-0.7×

Where this comes from

Reported directly by Cytek Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-053496
(In thousands, except share and per share data)Three Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Service15,58414,18730,94027,534
Total revenue, net48,14045,60292,27587,059
Cost of sales:
Product12,88414,92128,80530,450
Service6,9166,81413,87612,585
Total cost of sales19,80021,73542,68143,035
Gross profit28,34023,86749,59444,024
Operating expenses:

Item 1. Consolidated Financial Statements (Unaudited)

FAQ

What is Cytek Biosciences, Inc.'s product — total cost of sales?
Cytek Biosciences, Inc. (CTKB) reported product — total cost of sales of $12.88M in Q2 2026.
How has Cytek Biosciences, Inc.'s product — total cost of sales changed year-over-year?
Cytek Biosciences, Inc.'s product — total cost of sales decreased by 13.7% year-over-year, from $14.92M to $12.88M.
What is the long-term trend for Cytek Biosciences, Inc.'s product — total cost of sales?
Over 4 years (2021 to 2025), Cytek Biosciences, Inc.'s product — total cost of sales has grown at a 16.9% compound annual growth rate (CAGR), from $37.38M to $69.81M.
What does product — total cost of sales mean?
This metric captures the direct costs incurred to manufacture and deliver the company's physical products, including raw materials, labor, and overhead directly attributable to the production process. It is a critical measure for evaluating manufacturing efficiency and the direct profitability of the product segment. Monitoring this cost helps stakeholders understand the impact of supply chain dynamics and production scaling on the company's gross margins.

Ask your AI about Cytek Biosciences, Inc.'s product — total cost of sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude